Victory Capital Management Inc. Lowers Stock Position in HealthEquity, Inc. $HQY

Victory Capital Management Inc. reduced its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 11.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 170,430 shares of the company’s stock after selling 22,751 shares during the period. Victory Capital Management Inc. owned 0.20% of HealthEquity worth $16,152,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in HQY. Segall Bryant & Hamill LLC lifted its position in shares of HealthEquity by 2.5% during the 3rd quarter. Segall Bryant & Hamill LLC now owns 169,849 shares of the company’s stock worth $16,097,000 after buying an additional 4,107 shares in the last quarter. Elo Mutual Pension Insurance Co purchased a new stake in shares of HealthEquity during the third quarter valued at approximately $1,031,000. American Century Companies Inc. increased its position in shares of HealthEquity by 11.8% during the third quarter. American Century Companies Inc. now owns 771,205 shares of the company’s stock valued at $73,087,000 after acquiring an additional 81,464 shares during the last quarter. Xponance Inc. lifted its holdings in HealthEquity by 0.8% during the third quarter. Xponance Inc. now owns 12,265 shares of the company’s stock worth $1,162,000 after acquiring an additional 102 shares during the period. Finally, Westfield Capital Management Co. LP boosted its position in HealthEquity by 35.7% in the third quarter. Westfield Capital Management Co. LP now owns 1,716,658 shares of the company’s stock worth $162,688,000 after purchasing an additional 451,450 shares during the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

HealthEquity Trading Down 1.9%

Shares of HealthEquity stock opened at $78.50 on Wednesday. The stock has a market capitalization of $6.71 billion, a P/E ratio of 36.01, a P/E/G ratio of 1.00 and a beta of 0.26. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $116.65. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13. The stock’s 50-day simple moving average is $82.74 and its 200 day simple moving average is $90.63.

Insider Activity at HealthEquity

In related news, EVP Delano Ladd sold 1,500 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $94.72, for a total transaction of $142,080.00. Following the sale, the executive vice president directly owned 73,979 shares in the company, valued at approximately $7,007,290.88. This represents a 1.99% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Elimelech Rosner sold 10,959 shares of the firm’s stock in a transaction that occurred on Thursday, December 18th. The stock was sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the completion of the transaction, the executive vice president directly owned 45,742 shares of the company’s stock, valued at approximately $4,366,073.90. This trade represents a 19.33% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.50% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently issued reports on HQY. Citigroup reaffirmed an “outperform” rating on shares of HealthEquity in a research report on Thursday, December 4th. Barrington Research restated an “outperform” rating and set a $125.00 price objective on shares of HealthEquity in a report on Thursday, December 4th. JPMorgan Chase & Co. lifted their price objective on shares of HealthEquity from $126.00 to $129.00 and gave the stock an “overweight” rating in a research report on Thursday, December 4th. Barclays reduced their target price on shares of HealthEquity from $118.00 to $110.00 and set an “overweight” rating for the company in a research report on Wednesday, February 18th. Finally, The Goldman Sachs Group cut shares of HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 price target on the stock. in a report on Friday, January 9th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, HealthEquity currently has a consensus rating of “Moderate Buy” and an average target price of $112.00.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.